Effects of novel aggregation inhibitors on serotonin uptake by human blood platelets
- 1 March 1987
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 923 (3) , 443-450
- https://doi.org/10.1016/0304-4165(87)90053-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The effect of α,α′-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene on human blood platelet structural physiologyBiochimica et Biophysica Acta (BBA) - Biomembranes, 1984
- Relationships between the chemical constitution of aggregation inhibitors and human blood platelet response profileBiochimica et Biophysica Acta (BBA) - Biomembranes, 1984
- Inhibition of human platelet function by verapamilThrombosis Research, 1982
- Inhibition of 5-hydroxytryptamine-induced and-amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonistInflammation Research, 1982
- Human Blood Platelet Aggregation-inhibitory Target Sites Assumed to Involve Membrane PhospholipidsBiophysical Journal, 1982
- Surface activity and human blood platelet aggregation-inhibitory potencyChemico-Biological Interactions, 1982
- Interaction of human blood platelet aggregation inhibitors with phospholipid filmsThrombosis Research, 1981
- Relationships between the chemical constitution of carbamoylpiperidines and related compounds, and their inhibition of ADP-induced human blood platelet aggregationThrombosis Research, 1981
- The effect of various inhibitors on the 5-ht binding and uptake by human plateletsThrombosis Research, 1981
- Human blood platelets as cellular models for investigation of membrane active drugs: Beta-adrenergic blocking agentsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1972